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Some very preterm neonates admitted to the neonatal inten-
sive care unit show circulatory and respiratory problems that
improve after administration of steroids. It is unclear whether
these symptoms could be caused by adrenal insufficiency. The
objective of our study was to investigate the cortisol levels and
the cortisol release from the adrenals after ACTH in very preterm
infants with and without severe illness and to find whether a
relation exists between adrenal function and outcome. An ACTH
test (0.5 mg) was performed on d 4 in 21 very preterm infants
(gestational age, 25.6–29.6 wk; birth weight, 485–1265 g). Base-
line cortisol and 17-hydroxyprogesterone (17OHP) levels and the
cortisol levels 30, 60, and 120 min after ACTH administration
were measured. The Score for Neonatal Acute Physiology was
used to measure illness severity. All infants showed an increase
in cortisol levels after ACTH, but the cortisol levels were sig-
nificantly lower in the ventilated more severely ill infants. After
adjusting for birth weight and gestational age, the mean baseline
cortisol levels and cortisol/17OHP ratios were significantly lower
and the 17OHP levels significantly higher in the ventilated
infants compared with the nonventilated infants. Patients with an
adverse outcome had significantly lower baseline cortisol/
17OHP ratios and 60-min cortisol levels during ACTH testing
(p 5 0.002 and p 5 0.03, respectively). These data suggest an
insufficient adrenal response to stress in sick ventilated very
preterm infants with gestational ages younger than 30 wk com-
pared with nonventilated less sick preterm infants. Further stud-
ies are required to investigate whether supplementation with
physiologic doses of hydrocortisone may benefit the outcome.
(Pediatr Res 48: 629–633, 2000)
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With increasing neonatal and obstetric treatment modalities,
younger and smaller neonates are admitted to neonatal inten-
sive care units (NICU). Some of these infants show not only
respiratory but also circulatory problems such as systemic
hypotension resistant to volume expansion and cardiotonic
drugs but reactive to the administration of corticosteroids (1).
Declining cortisol levels in the first week of life in patients with
ongoing respiratory problems are reported (2), and a higher
incidence of bronchopulmonary dysplasia (BPD) in patients
with an insufficient cortisol response to ACTH has been found
(3).
In the 1970s, the adrenal function of preterm neonates was
investigated after administration of a short course of cortico-
steroids during gestation, and no signs of adrenal insufficiency
were found (4). These preterm neonates, however, were born
after a greater gestational age, had a higher birth weight than
the infants presently seen in the NICU, and were tested with a
relatively high dose of ACTH (15 mg/kg) on the first day of
life. In infants exposed to long courses of corticosteroids
during gestation, no evidence of adrenal insufficiency was
found when tested with a higher dose of ACTH (36 mg/kg) (5).
These infants, however, were of greater gestational age com-
pared with the very preterm infants now treated at the NICU.
Insufficient cortisol production may not only lead to dis-
turbed vital signs such as low blood pressure and poor glyce-
mic control but also may influence illness severity and out-
come.
According to previous studies, cortisol and 17OHP levels
are high on the first day of life. Thereafter, cortisol levels
decrease immediately and tend to increase at d 4 and 5,
whereas 17OHP levels decline immediately after birth but
remain stable from d 2 until 7 (6–9). Recent studies show low
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cortisol levels in ill very preterm infants (10–13), whereas
others find low cortisol levels that may be explained as phys-
iologic as these infants no longer required mechanical ventila-
tion (14). Cortisone levels decline immediately in the first 2 h
and very gradually thereafter in the first week of life. The
levels between term and preterm infants are not significantly
different. Corticosterone levels are much lower than cortisol
levels, increase in the first 2 h, decrease until 6 h, and decrease
again to 24 h, after which a slight increase is seen.
The aim of the present study was to investigate the release of
cortisol and the precursor 17OHP from the adrenals of very
preterm infants under conditions of stress compared with the
nonstressed situation and to evaluate whether a relation exists
between the cortisol release on d 4 of life and the development
of BPD, severe cerebral complications, and mortality.
METHODS
Patients
Twenty-one patients admitted to the NICU of the Sophia
Children’s Hospital were included in the present study. The
inclusion criteria were immediate admission at the intensive
care unit after birth, gestational age younger than 30 wk, and
indwelling arterial line. Exclusion criteria were a maternal
history of endocrine disorders such as diabetes, thyroid or
adrenal problems, or congenital malformations. The present
study was approved by the local Medical Ethics Committee,
and informed consent was obtained from the parents of each
child.
Infants were studied on d 4 of life. Most of the infants were
tested at 0800 h, but some were tested in the afternoon. A
standard dose of 0.5 mg of ACTH was given. ACTH was
diluted with saline to a concentration of 1 mg/mL in a plastic
syringe and immediately given i.v. by a short venous cannula
and a connection close to the patient.
Baseline blood samples for cortisol, 17OHP, and C/17OHP
were taken. Cortisol was also measured 30, 60, and 120 min
after administration of ACTH. All blood samples were taken
from an indwelling arterial line. Oxygen saturation was mea-
sured continuously by pulse oxymetry (Nellcor 3000), venti-
lation settings were recorded every 30 min during testing, and
arterial blood pressure was measured continuously.
Illness severity was measured by the SNAP score (15). We
performed this score on d 4 to determine whether other patho-
physiologic parameters such as blood pressure, frequency of
bradycardia, disturbances in glucose, in serum electrolytes, and
liver or kidney function, often seen in more severely ill patients
and not always accompanied by higher ventilation settings,
were related to the adrenal function. Although the SNAP score
is designed to reflect the severity of illness on d 1, we believe
that the score on d 4 also reflects the severity of illness on d 4.
BPD was defined as persisting respiratory problems with a
need for oxygen at d 28 and an abnormal chest x-ray (16).
Adverse outcome was defined as mortality or severe morbidity
defined by severe cerebral problems (intracranial hemorrhage
grade 3 or more and severe cystic leukomalacia) and/or BPD.
Hormone Assays
Serum cortisol was determined by using a commercial
chemiluminescent labeled antibody assay (Nichols Institute
Diagnostics Cortisol Kit, San Juan Capistrano, CA, U.S.A.).
The intraassay coefficients of variation were 3.1–4.8%, and the
interassay coefficients of variation were 6.2–10.2%. Cross-
reactivity with cortisone is unknown within physiologic
ranges. Hyperbilirubinemia did not influence the assay.
The precursor 17OHP was determined by RIA (Coat-A-
Count, Diagnostic Products Corp., Los Angeles, CA, U.S.A.)
(Laboratory Internal Medicine, Academic Hospital Rotterdam,
The Netherlands; Head, Prof. Dr. F. de Jong). The interassay
coefficient of variation was 10% for 17OHP. The main cross-
reactivity in the 17OHP assay occurred with progesterone 5%
(17).
Statistical Analyses
Statistical analyses were made by SPSS package, version 8.0
for Windows, released in 1997. Results are expressed as mean
(SD) unless indicated otherwise.
Linear regression analysis was used to examine the relations
between determinants such as birth weight, gestational age,
birth weight SD score (SDS), illness severity, and ventilation
and continuous outcome variables such as cortisol, 17OHP,
and C/17OHP. The relation with ventilation, BPD, and adverse
outcome was adjusted for gestational age and birth weight.
The baseline 17OHP data showed a skewed distribution and
were log transformed for statistical analyses.
A p value , 0.05 was considered significant.
RESULTS
Twenty-one patients were enrolled in the study (14 male,
seven female); the patients had a mean gestational age of 27.7
wk [interquartile (i.q.) range, 26.4–28.9 wk], a mean birth
weight of 887 g (i.q. range, 708–1005 g), a mean SDS for birth
weight of 21.43 (i.q. range, 22.82 to 20.30), and a mean
weight at day of testing of 845 g (i.q. range, 738–933 g).
Sixteen patients received antenatal betamethasone, and 10
patients were artificially ventilated during ACTH testing. The
ventilated and nonventilated group were not significantly dif-
ferent except for gestational age, birth weight, and SNAP score
(p 5 0.03, p 5 0.03, and p 5 0.003, respectively). The ACTH
dose expressed in mg/kg was not significantly different be-
tween the groups. Five patients died in the neonatal period.
Baseline Cortisol Levels
The mean (SD) baseline cortisol level for the total group was
277 (144) nmol/L. The baseline cortisol levels were not influ-
enced by the mode of delivery or the presence of preeclampsia
in the mother and did not correlate with gestational age, birth
weight, and birth weight SDS.
In boys, the mean baseline cortisol level was 116 nmol/L
lower than in girls (p 5 0.21). In the patients treated with
antenatal steroids, the mean baseline cortisol level was not
significantly lower compared with the group without use of
antenatal steroids.
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Cortisol Response after ACTH
The mean (SD) cortisol levels 30 and 60 min after ACTH
administration were 558 (180) and 753 (250) nmol/L, respec-
tively. Some infants continued to have high cortisol levels at
120 min, but others already showed a decline. The mean (SD)
cortisol level at 120 min was 694 (251) nmol/L.
The cortisol levels at 30 and 60 min were positively corre-
lated with gestational age (r 5 0.57, p 5 0.008 and r 5 0.59,
p 5 0.006, respectively). The 60-min cortisol levels showed a
positive correlation with birth weight (r 5 0.49, p 5 0.029).
The cortisol levels at 30 and 60 min were not correlated with
the ACTH dose per kilogram of body weight (r 5 20.26, p 5
0.26 and r 5 20.43, p 5 0.06, respectively) or with birth
weight SDS (r 5 20.23, p 5 0.92 and r 5 0.82, p 5 0.73).
Baseline 17OHP Levels
The baseline levels of 17OHP showed a skewed distribution
and were log transformed for statistical analyses. The baseline
17OHP levels showed a negative correlation with gestational
age (r 5 20.53, p 5 0.020) but did not correlate with birth
weight or birth weight SDS. The baseline 17OHP levels were
not related with the baseline cortisol levels but were negatively
correlated with the cortisol levels at 30 and 60 min (r 5 20.52,
p 5 0.025 and r 5 20.51, p 5 0.032, respectively).
Cortisol and 17OHP Levels in Relation to Ventilation
The mean baseline cortisol level was not significantly lower,
but the cortisol levels at 30 and 60 min after administration of
ACTH were significantly lower in the ventilated infants com-
pared with the nonventilated infants (p , 0.001 and p , 0.01,
respectively) (Fig. 1). The mean baseline 17OHP level in the
ventilated infants was 45.6 (34.3) nmol/L and significantly
higher compared with the nonventilated infants 8.5 (6.4)
nmol/L (p 5 0.014). The mean baseline C/17OHP was signif-
icantly lower in the ventilated compared with the nonventilated
infants (p 5 0.004). After adjusting for gestational age and
birth weight, the mean baseline cortisol, the cortisol level at 30
min, and the C/17OHP were significantly lower in the venti-
lated group (p 5 0.046, p 5 0.013, and p 5 0.015, respective-
ly).
Cortisol and 17OHP Levels in Relation to Illness Severity
The baseline cortisol levels were not related to SNAP scores,
but the 30- and 60-min cortisol levels were negatively corre-
lated with higher SNAP scores, indicating lower cortisol levels
at higher SNAP scores (r 5 20.62, p 5 0.005 and r 5 20.61,
p 5 0.006, respectively) (Fig. 2, A– C). For every increment of
10 points in the SNAP score, the 30-min cortisol level de-
creased with 215 nmol/L and the 60-min cortisol level de-
creased with 272 nmol/L.
The baseline 17OHP level was positively correlated with
higher illness severity as measured by SNAP (r 5 0.49, p 5
0.039).
Cortisol and 17OHP Levels in Relation to Outcome
BPD. Patients who developed BPD were not significantly
different with respect to gestational age, birth weight, and birth
weight SDS compared with patients who did not develop BPD.
Patients who developed BPD showed a significantly lower
mean cortisol level at 60 min (p 5 0.029) than patients who did
not develop BPD. In addition, the mean baseline value for
17OHP was significantly higher and mean C/17OHP was
significantly lower in infants who developed BPD (p 5 0.009
and p 5 0.008, respectively).
Adverse outcome. Gestational age, birth weight, and birth
weight SDS were not significantly different in patients with a
poor outcome compared with patients with a good outcome.
Patients with a poor outcome showed a significantly lower
mean 60-min cortisol level (p 5 0.025), a significantly higher
mean baseline 17OHP level (p 5 0.006), and a significantly
lower mean baseline C/17OHP (p 5 0.002) compared with
infants with a better outcome.
DISCUSSION
We performed this study to evaluate the capacity of the
adrenals of very preterm infants in the first week of life to
produce cortisol under normal conditions and under conditions
of stress.
Our study suggests that sick very preterm infants do not
release more cortisol than less severely ill very preterm infants.
Our data show significantly lower baseline cortisol levels and
a diminished cortisol response after ACTH in ventilated com-
pared with nonventilated infants and a significantly lower
C/17OHP in ventilated infants. A normal reaction to stress
would show a higher cortisol level with increasing illness as is
seen in critically ill adults (18). Our study, however, was not
designed to answer whether these infants became ill because of
a low cortisol production or showed adrenal insufficiency as a
result of their severe illness. The results, however, do support
the idea of considering supplementation of cortisol in severely
Figure 1. Cortisol levels before and after ACTH (0.5 mg) in ventilated and
nonventilated infants. Results are expressed as mean cortisol levels with 95%
confidence intervals. F 5 nonventilated infants, f 5 ventilated infants. ,p ,
0.001 vs nonventilated group, ,,p , 0.01 vs nonventilated group.
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ill very preterm infants with ongoing blood pressure problems
and persisting hypoglycemia.
Scott and Watterberg (19) have demonstrated that very sick
infants with gestational ages younger than 28 wk have lower
morning cortisol levels than less severely ill infants of the same
gestational age. This negative correlation between illness and
morning cortisol levels, however, seems diminished in patients
of greater gestational age. Other markers of illness such as
ventilatory support pattern or use of surfactant were also
negatively correlated with cortisol levels.
Our findings are in contrast with Hingre et al. (11) who
found in sick preterm and healthy full-term infants (20) com-
parable baseline cortisol levels and with Thomas et al. (21)
who even showed higher baseline cortisol levels in sick com-
pared with healthy preterm infants. The difference with our
data may be due to the fact that the patients in the Thomas
study had a gestational age greater than 30 wk, whereas our
patients were all younger than 30 wk.
In agreement with Lee et al. (10) and in contrast with other
studies (19, 22), we did not find a relation between baseline
cortisol level and gestational age. It could be that our popula-
tion was too homogeneous in gestational age to detect a
relationship.
Although we are not informed about the amount of cross-
reactivity between baseline cortisol and cortisone, we know
from other studies that the levels of cortisone can be in the
same range as the cortisol levels (8, 23, 24). This may have
contributed to the measured baseline cortisol levels, especially
when the baseline cortisol levels are low. We did find a
difference in baseline cortisol levels between ventilated and
nonventilated infants. As it is unlikely the levels of cortisone
were higher in ventilated compared with nonventilated infants,
the conclusion remains true.
The interpretation of ACTH test results is complicated by
the fact that no agreement exists about the correct dose of
ACTH, and different criteria for diagnosing adrenal insuffi-
ciency are used in the literature. We tested with a fixed dose of
0.5 mg, corresponding with an ACTH dose of 0.5–1 mg/kg or
10–15 mg/1.73 m2 and found differences between ventilated
and nonventilated infants.
The baseline cortisol levels in ventilated infants are remark-
ably low considering the degree of illness. Ventilated infants
do have significantly lower 30- and 60-min cortisol levels after
ACTH compared with nonventilated infants, which can only be
caused by a lower adrenal cortisol release in response to ACTH
administration. It is known from the literature that increases in
cortisol are much higher than increases in cortisone after
ACTH (23, 25). It is only when the increase in cortisol after
ACTH is very low that cortisone can still contribute to the
measured cortisol level. In fact, we may have underestimated
the differences in cortisol response between ventilated and
nonventilated infants.
Thus, in contrast with earlier studies (4, 26, 27), we found
evidence for adrenal insufficiency in very preterm ventilated
infants when tested with a low-dose ACTH. It seems that the
adrenals in these ventilated sick infants are less capable of
releasing cortisol after an additional ACTH stimulus compared
with nonventilated infants. Possible explanations may be that
Figure 2. (A) Baseline cortisol levels in relation to illness severity (SNAP
score). (B) Thirty-minute cortisol levels after ACTH administration in relation
to illness severity; regression line: C30 5 797 2 22 SNAP. (C) Sixty-minute
cortisol levels after ACTH administration in relation to illness severity;
regression line: C60 5 1041 2 27 SNAP.
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the adrenals in these infants were already down-regulated by
high circulating interleukin levels and no longer reactive to
high serum ACTH levels or that the adrenals in the ventilated
infants were not capable enough of recognizing higher serum
ACTH levels. The ventilated infants, however, showed higher
levels of the cortisol precursor 17OHP and a lower C/17OHP
compared with nonventilated infants. This indicates that the
adrenals are responsive to ACTH and produce precursors but,
at the same time, may not be able to convert the precursor to
cortisol. Hanna et al. (27) reported a normal ACTH and
cortisol response to ovine corticotropin releasing hormone
(CRH) and a normal cortisol response to exogenous ACTH in
extremely low birth weight infants, thereby suggesting that the
low baseline cortisol levels were partly due to an inability of
the brain to recognize the stress of illness or an inability of the
hypothalamus to secrete CRH. They, however, used a high
dose of ACTH (62.5 mg) and 1 d after CRH testing, which by
itself induces an increase in baseline cortisol levels. Ng et al.
(28) showed a higher ACTH response after CRH administra-
tion in ventilated infants without an increase in cortisol levels,
suggesting that the pituitary is more matured than the adrenals
in preterm infants.
Our study showed significantly higher 17OHP levels and
lower C/17OHP in ventilated infants compared with nonven-
tilated infants adjusted for gestational age and birth weight as
well as in more severely ill infants. Both suggest a reaction of
the adrenals to stress by increasing a cortisol precursor but
showing a lower capacity, especially in the severe ill and
ventilated infants, to convert this precursor 17OHP to cortisol.
The high levels of 17OHP in relation to cortisol can be caused
by a decreased activity of the enzyme CYP21A2 or due to a
lower conversion of 11-deoxycortisol to cortisol by CYP11B,
which seems to be a greater problem in the sick very preterm
infant. Higher 17OHP levels in sick preterm infants compared
with term infants have been described earlier (10, 29, 30). High
baseline levels of 17OH-pregnenolone, 17OHP, and 11-
desoxycortisol in sick infants with gestational ages younger
than 30 wk compared with term infants have been reported and
are also consistent with a decreased CYP11B activity (11).
In summary, our data demonstrate lower baseline cortisol
levels, a lower cortisol response to ACTH, higher 17OHP
levels, and lower C/17OHP in ventilated very preterm infants
compared with nonventilated preterm infants and those who
did not have an adverse outcome. The data suggest an insuf-
ficient adrenal response to stress in sick ventilated very preterm
infants with gestational ages younger than 30 wk. Further
studies are required to investigate whether supplementation
with physiologic doses of hydrocortisone may benefit the
outcome.
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